Anna Tutusaus

940 total citations
22 papers, 702 citations indexed

About

Anna Tutusaus is a scholar working on Immunology, Hepatology and Surgery. According to data from OpenAlex, Anna Tutusaus has authored 22 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 8 papers in Hepatology and 6 papers in Surgery. Recurrent topics in Anna Tutusaus's work include Liver physiology and pathology (7 papers), Phagocytosis and Immune Regulation (7 papers) and Cancer Mechanisms and Therapy (5 papers). Anna Tutusaus is often cited by papers focused on Liver physiology and pathology (7 papers), Phagocytosis and Immune Regulation (7 papers) and Cancer Mechanisms and Therapy (5 papers). Anna Tutusaus collaborates with scholars based in Spain, United States and Netherlands. Anna Tutusaus's co-authors include Albert Morales, Montserrat Marı́, Anna Colell, Pablo Garcı́a de Frutos, Blanca Cucarull, Estefanía de Gregorio, José C. Fernández‐Checa, Milica Stefanović, Carmen García‐Ruiz and Vicente Roca‐Agujetas and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and Journal of Hepatology.

In The Last Decade

Anna Tutusaus

22 papers receiving 698 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Tutusaus Spain 13 285 189 151 130 114 22 702
Dipti Athavale United States 14 271 1.0× 80 0.4× 178 1.2× 121 0.9× 98 0.9× 24 659
Caryn L. Elsegood Australia 16 227 0.8× 203 1.1× 161 1.1× 140 1.1× 130 1.1× 30 692
Ulrike A. Köhler Switzerland 12 369 1.3× 116 0.6× 260 1.7× 259 2.0× 134 1.2× 15 775
Xiaodong Peng China 18 410 1.4× 182 1.0× 84 0.6× 44 0.3× 74 0.6× 49 873
Yitao Ou China 13 300 1.1× 121 0.6× 145 1.0× 117 0.9× 71 0.6× 19 603
Catherine Lucas‐Clerc France 13 186 0.7× 227 1.2× 171 1.1× 104 0.8× 245 2.1× 22 709
Eszter Trojnár United States 11 164 0.6× 160 0.8× 234 1.5× 142 1.1× 118 1.0× 16 647
Wang‐Xiang Xu China 12 475 1.7× 69 0.4× 122 0.8× 111 0.9× 87 0.8× 23 755
Saijun Fan China 11 257 0.9× 82 0.4× 120 0.8× 61 0.5× 40 0.4× 32 581
Kazuo Tsukidate Japan 12 247 0.9× 113 0.6× 105 0.7× 75 0.6× 87 0.8× 32 687

Countries citing papers authored by Anna Tutusaus

Since Specialization
Citations

This map shows the geographic impact of Anna Tutusaus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Tutusaus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Tutusaus more than expected).

Fields of papers citing papers by Anna Tutusaus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Tutusaus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Tutusaus. The network helps show where Anna Tutusaus may publish in the future.

Co-authorship network of co-authors of Anna Tutusaus

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Tutusaus. A scholar is included among the top collaborators of Anna Tutusaus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Tutusaus. Anna Tutusaus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tutusaus, Anna, Marco Sanduzzi‐Zamparelli, Loreto Boix, et al.. (2024). Induction of the Inflammasome Pathway by Tyrosine Kinase Inhibitors Provides an Actionable Therapeutic Target for Hepatocellular Carcinoma. Cancers. 16(8). 1491–1491. 4 indexed citations
2.
Tutusaus, Anna, Albert Morales, Pablo Garcı́a de Frutos, & Montserrat Marı́. (2024). GAS6/TAM Axis as Therapeutic Target in Liver Diseases. Seminars in Liver Disease. 44(1). 99–114. 4 indexed citations
3.
Tutusaus, Anna, Loreto Boix, María Reig, et al.. (2024). Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASH. Frontiers in Immunology. 15. 1400553–1400553. 6 indexed citations
4.
Gregorio, Estefanía de, et al.. (2023). Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice. Biology of Sex Differences. 14(1). 85–85. 11 indexed citations
5.
Cucarull, Blanca, Anna Tutusaus, Pablo Garcı́a de Frutos, et al.. (2022). Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances. Cancers. 14(3). 621–621. 49 indexed citations
6.
Morales, Albert, Silvia Rojo‐Rello, Aida Fiz‐López, et al.. (2021). Growth Arrest-Specific Factor 6 (GAS6) Is Increased in COVID-19 Patients and Predicts Clinical Outcome. Biomedicines. 9(4). 335–335. 24 indexed citations
7.
Cucarull, Blanca, Anna Tutusaus, Pablo Garcı́a de Frutos, et al.. (2021). Antioxidants Threaten Multikinase Inhibitor Efficacy against Liver Cancer by Blocking Mitochondrial Reactive Oxygen Species. Antioxidants. 10(9). 1336–1336. 17 indexed citations
8.
Marı́, Montserrat, Estefanía de Gregorio, Cristina de Dios, et al.. (2020). Mitochondrial Glutathione: Recent Insights and Role in Disease. Antioxidants. 9(10). 909–909. 126 indexed citations
9.
Cucarull, Blanca, Anna Tutusaus, Milica Stefanović, et al.. (2020). Regorafenib Alteration of the BCL-xL/MCL-1 Ratio Provides a Therapeutic Opportunity for BH3-Mimetics in Hepatocellular Carcinoma Models. Cancers. 12(2). 332–332. 22 indexed citations
10.
Tutusaus, Anna, Montserrat Marı́, Jose T. Ortiz‐Pérez, et al.. (2020). Role of Vitamin K-Dependent Factors Protein S and GAS6 and TAM Receptors in SARS-CoV-2 Infection and COVID-19-Associated Immunothrombosis. Cells. 9(10). 2186–2186. 40 indexed citations
11.
Tutusaus, Anna, Estefanía de Gregorio, Blanca Cucarull, et al.. (2019). A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target. Cellular and Molecular Gastroenterology and Hepatology. 9(3). 349–368. 50 indexed citations
12.
Tutusaus, Anna, Milica Stefanović, Loreto Boix, et al.. (2018). Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma. Oncotarget. 9(24). 16701–16717. 48 indexed citations
13.
Tutusaus, Anna, Mario Štefanović, Blanca Cucarull, et al.. (2018). Sorafenib/Regorafenib resistance and BH3-mimetics efficacy in hepatocellular carcinoma treatment is determined by mitochondrial changes in the BCL-2 profile. Journal of Hepatology. 68. S686–S687. 1 indexed citations
14.
Tutusaus, Anna, et al.. (2018). AXL increase in NASH patients and anti-fibrotic efficacy of AXL inhibition in experimental NASH. Journal of Hepatology. 68. S394–S394. 1 indexed citations
15.
Pulido, Álvaro de Mingo, Estefanía de Gregorio, Anna Moles, et al.. (2016). Cysteine cathepsins control hepatic NF-κB-dependent inflammation via sirtuin-1 regulation. Cell Death and Disease. 7(11). e2464–e2464. 55 indexed citations
16.
Pujadas, Gemma, Sara Cervantes, Anna Tutusaus, et al.. (2016). Wnt9a deficiency discloses a repressive role of Tcf7l2 on endocrine differentiation in the embryonic pancreas. Scientific Reports. 6(1). 19223–19223. 9 indexed citations
17.
Stefanović, Milica, Anna Tutusaus, Cristina Bárcena, et al.. (2016). Targeting glucosylceramide synthase upregulation reverts sorafenib resistance in experimental hepatocellular carcinoma. Oncotarget. 7(7). 8253–8267. 45 indexed citations
18.
Bárcena, Cristina, Milica Stefanović, Anna Tutusaus, et al.. (2015). Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation. Journal of Hepatology. 63(3). 670–678. 115 indexed citations
19.
Bárcena, Cristina, Milica Stefanović, Anna Tutusaus, et al.. (2015). Angiogenin Secretion From Hepatoma Cells Activates Hepatic Stellate Cells To Amplify A Self-Sustained Cycle Promoting Liver Cancer. Scientific Reports. 5(1). 7916–7916. 40 indexed citations
20.
Ejarque, Miriam, et al.. (2013). Neurogenin3 Cooperates with Foxa2 to Autoactivate Its Own Expression. Journal of Biological Chemistry. 288(17). 11705–11717. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dipti Athavale Breakdown of academic impact, for papers by Caryn L. Elsegood Breakdown of academic impact, for papers by Ulrike A. Köhler Breakdown of academic impact, for papers by Xiaodong Peng Breakdown of academic impact, for papers by Yitao Ou Breakdown of academic impact, for papers by Catherine Lucas‐Clerc Breakdown of academic impact, for papers by Eszter Trojnár Breakdown of academic impact, for papers by Wang‐Xiang Xu Breakdown of academic impact, for papers by Saijun Fan Breakdown of academic impact, for papers by Kazuo Tsukidate
Rankless by CCL
2026